Senior Scientist, CAR-T & Lentiviral Vector Engineering

Bristol-Myers Squibb; Seattle (WA); On-site; USD 136,000 - 165,000; Full time

Benefits offered by this job

Flexible Time Off

Paid Vacation

Holidays

Wellbeing benefits

Retirement plan

Job summary

Bristol Myers Squibb in Seattle is seeking a Senior Scientist, Cell Therapy Research, Molecular Immunobiology and Discovery, to advance lentiviral vector platforms and CAR‑T cell engineering. You will design, execute and interpret studies to push next-generation cell therapies toward clinic readiness.

The role requires a strong background in molecular biology and immunology, with experience in lentiviral transduction, T‑cell biology, and data-driven decision making in a fast-paced environment.

Qualifications

• Bachelor’s degree with 7+ years of experience in life sciences.
• Master’s degree with 5+ years of experience in academic/industry settings.
• Ph.D. or equivalent with 2+ years of experience in life sciences.

Responsibilities

• Plan and execute studies to build next-gen lentiviral vectors for CAR‑T cells.
• Develop strategies to increase yield and throughput of lentiviral platforms.
• Collaborate with immunologists to interpret T-cell activation and differentiation data.
• Provide scientific insights on cross-functional programs and decision making.
• Supervise and guide junior team members toward project milestones.
• Design experiments and communicate progress for Go/No-Go decisions.
• Adopt novel methods and platforms across ongoing programs.

Skills

lentiviral vectors

CAR‑T cell biology

immunology basics

flow cytometry

communication

Education

Bachelor’s Degree

Master’s Degree

Ph.D. in Life Sciences

Tools

MSD

IncuCyte

flow cytometry

imaging

Job description

Bristol Myers Squibb in Seattle is seeking a Senior Scientist, Cell Therapy Research, Molecular Immunobiology and Discovery, to advance lentiviral vector platforms and CAR‑T cell engineering. You will design, execute and interpret studies to push next-generation cell therapies toward clinic readiness.

The role requires a strong background in molecular biology and immunology, with experience in lentiviral transduction, T‑cell biology, and data-driven decision making in a fast-paced environment.